Achieve Life Sciences, Inc.
ACHV· Nasdaq
Filed Aug 2, 2012 · 10-Q · 33 days after period end · 0001193125-12-331889
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Net Income | -$4.22M | -$6.53M | $154.00K |
| EPS Diluted | -$0.29 | -$0.67 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 2, 2012 · 33 d after period end